GlassScriptPhysician profile
Todd R Nelson
NPI 1902917495
$5,919.50
in general payments reported to CMS, 2019-2025
55 companies · $985 in 2025
The $985 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,008 · 2020: $412 · 2021: $746 · 2022: $1,040 · 2023: $897 · 2024: $832 · 2025: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,713.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $785.86 | 2019-2025 | |
| Lilly USA, LLC | $447.07 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $407.26 | 2019-2025 | Jardiance, Cyltezo, Synjardy |
| Glaxosmithkline, LLC. | $348.98 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Amgen INC. | $297.41 | 2019-2025 | Evenity, Prolia, Tavneos |
| Pfizer INC. | $295.37 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $261.34 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $249.71 | 2019-2025 | Spravato, Xarelto |
| Merck Sharp & Dohme LLC | $248.43 | 2019-2024 | Verquvo, Gardasil 9, Gardasil |
| Novo Nordisk INC | $234.55 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $219.18 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $197.76 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $163.00 | 2019-2022 | |
| Viiv Healthcare Company | $124.11 | 2023-2025 | Apretude |
| Gilead Sciences, INC. | $102.86 | 2019-2025 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.